Clinical Trial Update: Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment

View source ↗

Summary

This entry reports a clinical trial evaluating a rice-derived recombinant human serum albumin for hypoalbuminemia or hypovolemia requiring urgent treatment; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoalbuminemia
• Hypovolemia

Drugs mentioned

• Recombinant human serum albumin from Oryza sativa (Recombinant human serum albumin (rice-derived))

Snippet

Sponsor: Healthgen Biotechnology Corp. | Conditions: Hypoalbuminemia, Hypovolemia | Status: NOT_YET_RECRUITING